Jendryczko, K.; Chudzian, J.; Skinder, N.; Opaliński, Ł.; Rzeszótko, J.; Wiedlocha, A.; Otlewski, J.; Szlachcic, A.
FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1. Cancers 2020, 12, 2992.
https://doi.org/10.3390/cancers12102992
AMA Style
Jendryczko K, Chudzian J, Skinder N, Opaliński Ł, Rzeszótko J, Wiedlocha A, Otlewski J, Szlachcic A.
FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1. Cancers. 2020; 12(10):2992.
https://doi.org/10.3390/cancers12102992
Chicago/Turabian Style
Jendryczko, Karolina, Julia Chudzian, Natalia Skinder, Łukasz Opaliński, Jakub Rzeszótko, Antoni Wiedlocha, Jacek Otlewski, and Anna Szlachcic.
2020. "FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1" Cancers 12, no. 10: 2992.
https://doi.org/10.3390/cancers12102992
APA Style
Jendryczko, K., Chudzian, J., Skinder, N., Opaliński, Ł., Rzeszótko, J., Wiedlocha, A., Otlewski, J., & Szlachcic, A.
(2020). FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1. Cancers, 12(10), 2992.
https://doi.org/10.3390/cancers12102992